Australia markets closed

Roivant Sciences Ltd. (87S.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
6.65-0.76 (-10.26%)
As of 09:15AM CET. Market open.
Full screen
Previous close7.41
Open6.65
Bid7.02 x N/A
Ask7.74 x N/A
Day's range6.65 - 6.65
52-week range2.56 - 8.78
Volume250
Avg. volume32
Market cap5.026B
Beta (5Y monthly)1.30
PE ratio (TTM)N/A
EPS (TTM)-4.29
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Roivant Sciences Announces Pricing of Upsized Public Offering of Common Shares

    BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq: ROIV) today announced the pricing of an upsized underwritten public offering of 26,666,666 of its common shares at a price to the public of $7.50 per share. All of the common shares to be sold in the offering are to be sold by Roivant. The gross proceeds to Roivant from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expecte

  • GlobeNewswire

    Roivant Sciences Announces Proposed Public Offering of Common Shares

    BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Roivant Sciences Ltd. (Nasdaq: ROIV) announced today that it has commenced an underwritten public offering of $150 million of common shares. In addition, Roivant expects to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of common shares. All of the common shares are being offered by Roivant. The proposed offering is subject to market conditions and other factors, and the

  • GlobeNewswire

    Roivant to Report Financial Results for the Third Quarter Ended December 31, 2022 on Monday, February 13, 2023

    Quarterly investor call and webcast scheduled on Monday, February 13 at 8:00 a.m. ETRoivant will also participate in the SVB Securities Global Biopharma Conference in February and the Cowen 43rd Annual Health Care Conference in March BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq: ROIV) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Monday, February 13, 2023, to report its financial result